滚动资讯
FierceBiotechIndivior warns of ‘significant impact’ on R&D team after opioid use disorder drug fails phase 2FierceBiotechBMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecificEndpoints NewsWhat we heard at a health tech conference in BostonPromega Blog你未选择的过滤器FierceBiotechLabcorp上调全年业绩预期，受诊断及实验室服务提振FierceBiotechLeo Pharma支付5000万美元收购Replay及其临床前皮肤疾病基因疗法Endpoints NewsCVS医疗交付负责人看好临床人工智能潜力PharmaVoice辉瑞为畅销罕见病药物延长专利保护期FierceBiotechBeOne与中国华辉签署20亿美元预临床三特异性抗体期权协议BioWorldMFDS批准Curocell的anbal-cel为首个国产CAR-T疗法Cytiva (Google News)罗克韦尔自动化与Cytiva联合推出Figurate SCADA系统，消除生物制药制造中的数字瓶颈——制造业化学家Endpoints News礼来公司第一季度财报悬而未决：减肥药销售细节缺失受关注
Roche Media 2026年1月27日

Roche moves obesity drug to pivotal trials after mid-stage success - statnews.com

Roche moves obesity drug to pivotal trials after mid-stage success - statnews.com

原文
暂时没有全文，请查看原始来源。